1099 |
Optimal Management for Diabetic Patients with Ischemic Heart disease; Medical, Percutaneous, or Surgical Treatment |
Spencer B. King III |
May. 12. 11 |
1098 |
Is Diabetis Influence Different According to the Ethnics? Data From J-Cypher Registry |
Takeshi Kimura |
May. 12. 11 |
1097 |
Differential Treatment Effects of PCI vs. CABG in Diabetic and Non-Diabetic Patients |
David R. Holmes |
May. 12. 11 |
1096 |
Comparison of Sirolimus-eluting vs. Everolimus-eluting Stents in Diabetic and Non-Diabetic Patients: Results from the IRIS-DES Registry and the ESSENCE-DIABETES Clinical Trial |
Seung-Whan Lee |
May. 12. 11 |
1095 |
Is There Any Impact of Intravascular Ultrasound on Clinical Outcome in Bifurcation Tretament ? |
Imad Sheiban |
May. 12. 11 |
1094 |
Insights from FFR and IVUS for Bifurcation PCI |
Soo-Jin Kang |
May. 12. 11 |
1093 |
Gap Between Anatomy and Function |
William F. Fearon |
May. 12. 11 |
1092 |
Morphology and Distribution of Atherosclerotic Plaque |
Gaku Nakazawa |
May. 12. 11 |
1091 |
4D CT Reconstruction for Planning and Implementation of Structural Heart Disease Intervention |
Howard A. Cohen |
May. 12. 11 |
1090 |
For the CTO Intervention: Beyond Diagnosis and Treatment |
Wm. Guy Weigold |
May. 12. 11 |